The diabetes medication dulaglutide can significantly reduce the risk of weight gain after quitting smoking. This has been shown by a study published in the journal. BMJ Nutrition Prevention and Health.
255 smokers, 155 of whom were women, participated in the study. The average age ranged from 42 to 44 years, the number of cigarettes smoked per day averaged 20 cigarettes, and smoking experience ranged from 19 to 22 years. Patients were randomly assigned to receive the diabetes medication dulaglutide, a placebo, the smoking cessation medication varenicline, and help from a smoking cessation specialist for 12 weeks.
Women taking dulaglutide lost one to two pounds. On the other hand, patients who did not take the drug gained 2-2.5 kilos. Men taking dulaglutide lost an average of just over 500 grams of weight, while men in the placebo group gained about two pounds.
But women in the placebo group gained almost five times more weight than men. This means that taking dulaglutide when quitting smoking may be particularly beneficial for them, but more research is needed. This effect was not observed among men: Three of 56 men in the placebo group gained weight, and not a single patient of 44 in the dilaglutide group gained weight.
Previous scientists warned about the health and body dangers of secret overeating.